Furiex Pharmaceuticals, Inc.·4

May 29, 4:54 PM ET

Kaldor Stephen W 4

4 · Furiex Pharmaceuticals, Inc. · Filed May 29, 2013

Insider Transaction Report

Form 4
Period: 2013-05-24
Transactions
  • Award

    Common Stock

    2013-05-24+3,5803,580 total
Holdings
  • Stock Options (to buy)

    Exercise: $13.45Exp: 2021-10-12Common Stock (8,825 underlying)
    8,825
  • Stock Options (to buy)

    Exercise: $13.94Exp: 2021-05-19Common Stock (5,012 underlying)
    5,012
  • Stock Options (to buy)

    Exercise: $18.22Exp: 2022-05-24Common Stock (17,500 underlying)
    17,500
Footnotes (4)
  • [F1]The restricted stock was awarded on 5/24/2013 and vests in its entirety on the earlier of 5/24/2014 or immediately prior to the 2014 Annual Stockholder meeting, provided that the Grantee is still at that time serving on the Company's Board of Directors.
  • [F2]The options were awarded on 5/19/2011 and vest and become exercisable in full on the earlier of the first anniversary of the date of grant or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.
  • [F3]The options were awarded on 10/12/2011 and vest and become exercisable in full on the earlier of 5/19/2012 or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.
  • [F4]The options were awarded on 5/24/2012 and vest and become exercisable in full on the earlier of 5/24/2013 or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    PRIMARY DOCUMENT